Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients

Completed

Conditions studied: Neoplasms

In brief

The purpose of this study is to develop tests that will allow us to determine who will react differently to the drugs used to treat cancer. We also want to see who will react differently with preparing for a bone marrow transplant.

Key facts

Study ID

NCT00578630

Run by

Memorial Sloan Kettering Cancer Center

People needed

128

Starts

2003-10-14

Expected to finish

2018-11-01

Last updated by the study team

2018-11-19

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All Pediatric Oncology and Bone Marrow Transplantation Service patients with a histologically proven tumor for whom there is an intent to treat with chemotherapy are eligible for participation in this study. The patient does not need to be newly diagnosed for enrollment on this protocol.
• All patients or their guardians must provide written informed consent. Minors will be required to provide assent.

You may not qualify if…

• None

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.